A Study to Determine if Technosphere® Inhalation Powder (FDKP) Causes ECG Changes (QTc) Following the Medication's Inhaled Administration.

NCT00721344 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Technosphere Inhalation Powder (FDKP)
DRUG: Moxifloxacin
DRUG: Technosphere Inhalation Powder (FDKP)
DRUG: Placebo

Sponsor

Mannkind Corporation